AAAAAA
Results:
1-12
|
Results: 12
Authors:
Candell-Riera, J
Llevadot, J
Santana, C
Castell, J
Aguade, S
Armadans, L
Bermejo, B
Oller, G
Garcia-del-Castillo, H
Soler-Peter, M
Soler-Soler, J
Citation: J. Candell-riera et al., Prognostic assessment of uncomplicated first myocardial infarction by exercise echocardiography and Tc-99m tetrofosmin gated SPECT, J NUCL CARD, 8(2), 2001, pp. 122-128
Authors:
Llevadot, J
Giugliano, RP
Antman, EM
Wilcox, RG
Gurfinkel, EP
Henry, T
McCabe, CH
Charlesworth, A
Thompson, S
Nicolau, JC
Tebbe, U
Sadowski, Z
Braunwald, E
Citation: J. Llevadot et al., Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction, EUR HEART J, 22(22), 2001, pp. 2104-2115
Authors:
Giugliano, RP
Llevadot, J
Wilcox, RG
Gurfinkel, EP
McCabe, CH
Charlesworth, A
Thompson, SL
Antman, EM
Braunwald, E
Citation: Rp. Giugliano et al., Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis - Results from InTIME-II, EUR HEART J, 22(18), 2001, pp. 1702-1715
Authors:
Llevadot, J
Giugliano, RP
Antman, EM
Citation: J. Llevadot et al., Bolus fibrinolytic therapy in acute myocardial infarction, J AM MED A, 286(4), 2001, pp. 442-449
Authors:
Llevadot, J
Murasawa, S
Kureishi, Y
Uchida, S
Masuda, H
Kawamoto, A
Walsh, K
Isner, JM
Asahara, T
Citation: J. Llevadot et al., HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells, J CLIN INV, 108(3), 2001, pp. 399-405
Authors:
Sesmilo, G
Biller, BMK
Llevadot, J
Hayden, D
Hanson, G
Rifai, N
Klibanski, A
Citation: G. Sesmilo et al., Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: A randomized controlled trial, J CLIN END, 86(4), 2001, pp. 1518-1524
Authors:
Llevadot, J
Giugliano, RP
Citation: J. Llevadot et Rp. Giugliano, Pharmacology and clinical trial results of lanoteplase in acute myocardialinfarction, EXPERT OP I, 9(11), 2000, pp. 2689-2694
Authors:
Llevadot, J
Coulter, SA
Giugliano, RP
Citation: J. Llevadot et al., A practical approach to the diagnosis and management of thrombocytopenia associated with glycoprotein IIb/IIIa receptor inhibitors, J THROMB TH, 9(2), 2000, pp. 175-180
Authors:
de Lemos, JA
Antman, EM
Morrow, DA
Llevadot, J
Giugliano, RP
Coulter, SA
Schuhwerk, KC
Arslanian, S
McCabe, CH
Gibson, CM
Rifai, N
Citation: Ja. De Lemos et al., Heart-Type Fatty Acid Binding Protein as a marker of reperfusion after thrombolytic therapy, CLIN CHIM A, 298(1-2), 2000, pp. 85-97
Authors:
Sesmilo, G
Biller, BMK
Llevadot, J
Hayden, D
Hanson, G
Rifai, N
Klibanski, A
Citation: G. Sesmilo et al., Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency - A randomized, controlled clinical trial, ANN INT MED, 133(2), 2000, pp. 111-122
Authors:
Llevadot, J
Giugliano, RP
McCabe, CH
Cannon, CP
Antman, EM
Murphy, S
Gibson, CM
Citation: J. Llevadot et al., Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis in Myocardial Infarction [TIMI] trials), AM J CARD, 85(12), 2000, pp. 1409-1413
Authors:
Agullo, L
Garcia-Dorado, D
Inserte, J
Paniagua, A
Pyrhonen, P
Llevadot, J
Soler-Soler, J
Citation: L. Agullo et al., L-Arginine limits myocardial cell death secondary to hypoxia-reoxygenationby a cGMP-dependent mechanism, AM J P-HEAR, 45(5), 1999, pp. H1574-H1580
Risultati:
1-12
|